FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
The FDA was already understaffed and behind in inspections when the Trump administration began its layoffs. Here's what you ...
ZB Importing LLC has issued a recall for six varieties of Ülker snack rolls, biscuits and wafers due to undeclared wheat, ...
News Nation on MSN6h
FDA: Supplemental shakes linked to listeria causes 11 deaths(WTVO) — 11 people are dead after drinking frozen supplemental shakes linked to a listeria outbreak, according to the Federal ...
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Listeria monocytogenes infections lin ...
18hOpinion
More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...
United Natural Trading Inc. issued a recall for Wegmans organic dry roasted salted almonds in January because they were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback